Global Patent Index - EP 1429732 A4

EP 1429732 A4 2005-01-26 - A CORE FORMULATION

Title (en)

A CORE FORMULATION

Title (de)

KERNFORMULIERUNG

Title (fr)

FORMULATION DE NOYAU

Publication

EP 1429732 A4 (EN)

Application

EP 01952575 A

Priority

US 0121676 W

Abstract (en)

[origin: WO03005991A1] This invention relates to a modulating formulation comprising pioglitazone hydrochloride and a biguamide, e.g. metformin. In particular, the product comprises a core of the biguamide, e.g. metformin, at least a portion thereof has a layer or coat thereon of pioglitazone.

IPC 1-7

A61K 9/16; A61K 9/50; A61K 31/155; A61K 31/4439

IPC 8 full level

A61K 9/28 (2006.01); A61K 9/24 (2006.01); A61K 31/155 (2006.01); A61K 31/4439 (2006.01); A61K 45/06 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61K 47/42 (2006.01); A61P 3/10 (2006.01)

CPC

A61K 45/06 (2013.01); A61K 9/209 (2013.01); A61K 31/155 (2013.01); A61K 31/4439 (2013.01)

C-Set

  1. A61K 31/155 + A61K 2300/00
  2. A61K 31/4439 + A61K 2300/00

Citation (search report)

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family

WO 03005991 A1 20030123; AU 2001273310 B2 20041007; CA 2453784 A1 20030123; EP 1429732 A1 20040623; EP 1429732 A4 20050126; JP 2004536841 A 20041209; MX PA04000176 A 20041027